Evidence map›Paper›PMID 36718108›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2023

A Retrospective Study to Evaluate the Association Between the Glasgow Prognostic Score and Atrial Fibrillation, Stroke, and Mortality at 30 Days and at 1 Year After Coronary Artery Bypass Graft Surgery.

Esra Dönmez, Sevgi Özcan, Bülent Mert, Berk Özkaynak, Sevil Tuğrul, İrfan Şahin, Ertuğrul Okuyan

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Esra DönmezDepartment of Cardiology, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0003-4484-4259
Sevgi ÖzcanDepartment of Cardiology, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0002-0201-8314
Bülent MertDepartment of Cardiovascular Surgery, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0003-3774-1171
Berk ÖzkaynakDepartment of Cardiovascular Surgery, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0001-8855-1373
Sevil TuğrulDepartment of Cardiology, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0003-1896-0504
İrfan ŞahinDepartment of Cardiology, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0001-9165-7566
Ertuğrul OkuyanDepartment of Cardiology, Bagcilar Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0002-0626-2939
Bağcılar Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The Glasgow prognostic score (GPS) consists of a combination of serum C-reactive protein and albumin levels as indicators of systematic inflammatory response and nutritional status, respectively. The present retrospective study aimed to evaluate the association between the GPS and atrial fibrillation, stroke, and mortality at 30 days and 1 year after coronary artery bypass graft (CABG) surgery. MATERIAL AND METHODS Patients with chronic coronary syndromes who underwent CABG surgery between 2012 and 2019 in a single center were included. Preoperative GPS was calculated. Then, patients were grouped according to postoperative atrial fibrillation (POAF) development. Further, groups were formed to evaluate the relationship between GPS and 30-day and 1-year cardiovascular mortality as well as stroke development. RESULTS Patients who developed POAF had higher GPS, higher European System for Cardiac Operative Risk Evaluation (EuroSCORE II) score, advanced age, lower angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) use, lower left ventricular ejection fraction, and were more likely to be female and to have a history of carotid artery disease (P<0.05, for all). Additionally, GPS, EuroSCORE II, advanced age, and lower left ventricular ejection fraction were detected as independent risk factors for POAF development. When adverse outcomes were assessed, cardiovascular mortality at 30 days or 1 year, and stroke development at 1 year, were more frequent in patients with POAF. Moreover, POAF development was found to be an independent risk factor for adverse outcomes. Also, GPS was established as an independent risk factor both for 30-day and 1-year cardiovascular mortality (P<0.0001 and P=0.001, respectively). CONCLUSIONS GPS is an easy-to-calculate score that has reasonable diagnostic accuracy in determining the risk of POAF and stroke as well as 30-day and 1-year cardiovascular mortality.

Indexed as

Atrial FibrillationStrokeAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCoronary Artery BypassFemaleHumansMalePostoperative ComplicationsPrognosisRetrospective StudiesRisk FactorsStroke VolumeVentricular Function, LeftAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonists

Identifiers

PMID36718108
PMCPMC9898998
OpenAlexW4317215092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.